HR
ANGO icon

Howe & Rusling’s AngioDynamics ANGO Stock Holding History

Howe & Rusling’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-128
Closed -$3K – 353
2022
Q3 		$3K Hold
128
– – ﹤0.01% 759
2022
Q2 		$2K Sell
128
-15
-10% -$307 ﹤0.01% 840
2022
Q1 		$3K Sell
143
-35
-20% -$794 ﹤0.01% 761
2021
Q4 		$5K Buy
178
+4
+2% +$110 ﹤0.01% 655
2021
Q3 		$5K Sell
174
-8
-4% -$214 ﹤0.01% 626
2021
Q2 		$5K Hold
182
– – ﹤0.01% 600
2021
Q1 		$4K Sell
182
-92
-34% -$1.86K ﹤0.01% 658
2020
Q4 		$4K Sell
274
-89
-25% -$1.13K ﹤0.01% 653
2020
Q3 		$4K Buy
363
+117
+48% +$1.11K ﹤0.01% 582
2020
Q2 		$3K Buy
+246
New +$2.54K ﹤0.01% 598

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Howe & Rusling's ANGO Position: Q4 2022 in Review

Howe & Rusling sold out of AngioDynamics (ANGO) in Q4 2022, closing a stake of 128 shares — an estimated $3K sold.

Howe & Rusling first reported a position in ANGO in Q2 2020 and held it in 10 quarters. The position peaked at $5K in Q4 2021. 149 funds tracked by Wall St. Rank hold ANGO as of Q4 2022.

  • Howe & Rusling reported no remaining AngioDynamics position as of Q4 2022 after selling out during the quarter.
  • Howe & Rusling sold 128 AngioDynamics shares in Q4 2022, an estimated $3K.
  • Howe & Rusling first reported a position in AngioDynamics in Q2 2020 and held it in 10 quarters.
  • Howe & Rusling's AngioDynamics position peaked at $5K in Q4 2021.
  • 149 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.